Follow-on studies - IND-enabling GLP toxicology
Ended Awarded Last action
- Contract number
- 75N95022F00002
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $503,901
Award facts
- Contract value 100% obligated
- $503,901.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $503,901 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $503,901 Delivery Order to Sri International under the Pharmacology and Toxicology for Therapeutics Program Indefinite Delivery Indefinite Quantity master contract. Sri International will provide Follow-On Studies - Ind-Enabling GLP Toxicology from its West Menlo Park, California location between September 2022 and September 2024. Charles River Laboratories Montréal ULC will assist Sri International by conducting an In Vitro Hemolysis and Flocculation Study as a subcontractor.
Quick answers
Who was awarded contract 75N95022F00002?
75N95022F00002 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 16, 2022.
How much is contract 75N95022F00002 worth?
The government has obligated $503,901 on 75N95022F00002.
Which agency awarded contract 75N95022F00002?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00002, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95022F00002 an order under another contract?
Yes. 75N95022F00002 is a delivery order under HHSN271201600006I, an indefinite delivery contract, on Pharmacology and Toxicology for Therapeutics Program (PTTP).
Was contract 75N95022F00002 competed?
The extent of competition for 75N95022F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award